to treat drug intoxication using this system. We have overexpressing multidrug resistance protein.
and applied this system to dogs with digoxin intoxication.
alone. The clearance was 22.4 Ϯ 2.1 and 1.5 Ϯ 0.2 mL/min for We evaluated not only the efficacy of the system, but the PCTL-MDR and PCTL equipment, respectively. Inulin also its biocompatibility and related adverse reactions.
was not transported in either system. White blood cell and platelet counts were slightly reduced by the treatment while hematocrit was unchanged; the granulocyte elastase concentration was slightly increased.
METHODS

Conclusion. These data suggest that our new type of hybrid
Animal preparation
kidney can selectively remove digoxin sufficiently to reduce its systemic blood concentration in dogs with digoxin intoxication.
To establish an animal model of digoxin intoxication, Taking previous studies into consideration, this system may be the drug was injected (625 g/kg, intramuscularly) in a more powerful tool for the treatment of intoxication.
healthy dogs (body weight; 10 to 16 kg) every 12 hours for three days before the experiment [4] . Twelve hours after the final injection, the animals were anesthetized Although hemoperfusion is frequently used for the with an intravenous injection of pentobarbitrate-sodium treatment of drug intoxication [1] , this maneuver has (1 mg/kg). An additional injection was given when the some disadvantages and its usage is limited [2] . Advances animals awoke. Respiration was supported by a ventilain molecular biology and cell culture systems enabled us tor (350 mL tidal volume, 14 times/min; Respirator R-60; to develop a new type of hybrid organ. It may be possibleing the study by connecting the arterial cannula to a pressure transducer. 
Preparation of the hybrid kidney
modified Eagle's medium (DMEM)/Ham's F-12 with 10% fetal calf serum (FCS), 1 mL/min] in a CO 2 -incubaThe artificial hybrid kidney, designed especially for tor that was maintained at 37ЊC and 95% O 2 /5% CO 2 digoxin removal, has been described previously [3] . In for eight days [3] . A part of the connected tubing was brief, PCTL, a renal proximal tubule cell line, was origimade of silicon to enhance gas exchange in the incubator. nally made by adding SV40 large T antigen to a primary culture of rabbit S1 cells. cDNA of human MDR-1 was Evaluation of the hybrid kidney in digoxin-intoxicated dogs introduced to the PCTL by electroporation [5] . Cells For each experiment, ten modules were used that were that were resistant to the highest concentration of colconnected in parallel just before the treatment of digoxin chicine, a substrate of MDR-1, was cloned and named intoxication ( Fig. 1) . Comparison of the efficacy between PCTL-MDR. This clone possesses 10 times greater the systems treated with PCTL-MDR and PCTL was amount of MDR-1 protein and about 100 times larger evaluated by a randomized open cross-over design with K m and V max values for digoxin than PCTL, while the a two-week interval. The treatment with PCTL served transport capacity of paraaminohippurate (PAH) was as a control. On the day of the treatment, these modules similar between the two cell lines. Transcellular inulin were transferred from the incubator to a temperaturetransport was negligible in both.
controlled warm bath at 37ЊC with 95%O 2 -oxygenization To make a hybrid kidney, hollow-fiber module for after the parallel connection. The culture medium inside immunoisolation (Culture flo; Asahi Medical Co. Ltd., of the modules was replaced once with warm saline and Tokyo, Japan) was used for culture of these cells [3] . In then arterial blood of the dog was flowed in the system. short, the fiber was made by polyethylene, with surface During the experiment, the capillary lumen was perfused area being 200 cm 2 . About 1 ϫ 10 8 cells were injected with blood (10 mL/min) while the pericapillary side was to each module with acid soluble type I collagen (Sigma, counter-currently perfused with an artificial solution for St. Louis, MO, USA) at 8 days before the experiment.
hemofiltration (Sublood; Fuso Pharmaceutical Co. Once 1/8 of total cells were injected, culture medium Ltd., Osaka, Japan; composition in mmol/L, 140 Na ϩ , was started to circulate at 0.1 mL/min for 30 minutes 2K ϩ , 3.5 Ca ϩϩ , 1 Mg ϩϩ , 110 Cl Ϫ , 3.5 acetate, 25 following a 15-minute equilibration period. Next, the HCO Ϫ 3 , 0.52 glucose, 10 mL/min). Inulin was continumodule was rotated 45Њ around the long axis and the ously infused (20 mg/dL) from the arterial side of the same procedure was repeated. These procedures were module. Nafamostat mesilate (15 mg/h; Futhan; Torii performed to seed the cells equally in the module. After Pharmaceutical Co. Ltd., Tokyo, Japan) was continuthe cell injection for eight times, capillary side of the ously infused from the arterial side for anticoagulation during the procedure. module was perfused with culture medium [Dulbecco's During the treatment, arterial blood was drawn just before and at 30, 60 and 90 minutes after the initiation of the study to measure serum concentrations of digoxin, inulin and granulocyte elastase, and complete the blood cell count. Venous blood (just at the post-hybrid kidney) was also obtained at 30, 60 and 90 minutes after the initiation to measure same parameters. The digoxin and inulin concentrations of the artificial solution in the pericapillary side were determined also. Serum digoxin and inulin concentrations were measured by a monoclonal polarization immunoassay technique (TDx autoanalyzer; Dinabot Co.) [6] and the modified Jaffe's method with an autoanalyzer [7] . Granulocyte elastase was measured by an enzyme immunoassay (PMN elastase kit; Merck Immunoassay, Darmstadt, Germany) [8] .
The effects of hemodialysis with a machine not using cultured cells also were evaluated in digoxin-intoxicated dogs under a similar protocol.
Statistics
All data are shown as the mean Ϯ SE. Statistical evaluation was performed by one-way ANOVA and t test as appropriate. A P value less than 0.05 was regarded as 
RESULTS
After three days of the digoxin injection, all animals suffered from anorexia and lost body weight. Mean sethat flowed out from the pericapillary side of the modules rum digoxin concentration just before the treatment was is shown in Figure 3A . It was significantly higher by 2.89 Ϯ 0.10 ng/mL (N ϭ 14). Effects on the serum digoxin PCTL-MDR than by PCTL (3.4 Ϯ 0.5 and 0.3 Ϯ 0.1 concentration of the hybrid kidney with PCTL-MDR mg/90 min for PCTL-MDR and PCTL, respectively). In was shown in Figure 2A . The concentration of arterial the absence of cell culture, it was slightly higher (1.0 Ϯ side was dramatically reduced at 30 minutes after the 0.3 mg/90 min) than PCTL alone, but less than the PCTLinitiation and continued to decrease until the end of MDR group. The calculated digoxin clearance (that is, the treatment. Digoxin concentration at 90 minutes after amount of drug removed/mean arterial concentration) the initiation of the treatment was 0.92 Ϯ 0.11 ng/mL is shown in Figure 3B . It was about 15-fold greater in (N ϭ 7) . The concentrations of venous side were signifi-PCTL-MDR than in PCTL alone, and still about fourfold cantly lower than those of arterial side at each observation higher than the cell culture-free system. point. Although treatment with PCTL alone also slightly Changes of serum inulin concentration at arterial and but significantly reduced serum digoxin concentration, venous sides were monitored to verify the absence of the decrement was significantly smaller than that with leakage of the modules. This parameter was not changed PCTL-MDR (Fig. 2B) . In order to compare the efficacy during the treatment with PCTL-MDR or PCTL (Fig. 4) . of this equipment with that of an ordinary artificial kid-
The serum inulin concentration in the artificial solution ney, complementary studies were conducted in which drained from pericapillary side was lower than the detechemodialysis was performed in the absence of cultured tion threshold (0.5 mg/dL) in the PCTL-MDR and PCTL cells (Fig. 2C) . As can be seen, the slope of the decrease groups. Clearance of digoxin and inulin in the PCTL in the arterial digitalis concentration was steeper than alone group was lower than those in the control group. that of the hybrid kidney with PCTL alone, but less steep These results are compatible with our previous in vitro than that of the hybrid kidney with PCTL-MDR. The data [3] , and we believe that it may be because these apparent elimination half-life of digoxin in the experisolutes can pass more easily through the dialyzer memment with each type of module was 47.5 Ϯ 3.4, 212.1 Ϯ brane alone than through the membrane with PCTL. 10.3 and 173.2 Ϯ 7.7 minutes in the PCTL-MDR, PCTL Several parameters were measured to evaluate possiand control groups, respectively. Digoxin removal estimated by the amount of the drug in the artificial solution ble adverse reactions by this procedure. The change of Changes in the white blood cell count and platelets at the arterial side are shown in Figure 5 panels B and C, respectively. They were slightly but significantly reduced by the treatment, however, there was no difference between the PCTL-MDR and PCTL modules.
Serum granulocyte elastase from arterial blood was measured to evaluate the biocompatibility of the module. Figure 6 shows that, although the variable was signifi- hematocrit is shown in Figure 5A . Although a little clot-DISCUSSION ting was observed in the module during the treatment, the hematocrit value did not significantly decrease after This study extends our previous in vitro finding of a selective removal of digoxin, a substrate of MDR-1, by the treatment in either the PCTL-MDR or PCTL group. a tissue engineering system applied for the treatment of have to start the cell culture before the intoxication is detected, which is a disadvantage of this system. For future digoxin-intoxicated dogs. As expected, the application of this device in vivo removed a larger amount of digoxin, clinical situations, we believe that the cells could be continuously cultured in the device and thus be available in which was sufficient to reduce its serum concentration. To our knowledge, this is the first report showing the case of intoxication. If we can establish such a system, this device may be useful even in the clinical situation. usefulness of the hybrid kidney with the introduction of a responsible gene to renal cells for the treatment of We also measured serum granulocyte elastase to evaluate the biocompatibility of this system [11], and with drug intoxication.
Hemoperfusion with activated charcoal is frequently the treatment found it increased. As the increment was much lower than that by cardiopulmonary bypass in dogs used to treat digoxin intoxication, but it has some disadvantages [1, 2] . First, removal of the substance is not
[8], we think that such a change is acceptable. Nafamostat mesilate, which we used as the anticoagulant, is reported specific, and physiologically important materials in the body, such as protein and platelets, also are removed.
to protect neutrophil activation during hemodialysis and cardiopulmonary bypass [12, 13] and hybrid liver [14] . Thrombocytopenia is frequently observed in clinical situations after the procedure. We have previously reported
This agent might lead to the better biocompatibility of our system. that thrombocytopenia was seen in dogs with digoxin intoxication that had been hemoperfused with charcoal
We have recently reported that a ␤2-microglobulin adsorption column for the treatment of amyloidosis asso- [4] . Although the blood flow rates were not identical and therefore impossible to compare precisely, the platelet ciated with renal failure also possesses a higher capacity for digoxin clearance [4] . Although the apparent clearcount was reduced from 205,600 Ϯ 7842 to 32,340 Ϯ 6570/L (83.5% reduction) using the three-hour treatance seems to be greater than observed in the present study, precise comparison is impossible because of differment with charcoal. These data suggest that the severity of thrombocytopenia was mild and also that the removal ent blood flow rates between the two devices. To achieve a higher efficacy, the device must be improved to endure of digoxin is more specific during the treatment with the hybrid kidney. Our finding that inulin transport was the higher blood flow rate. On the other hand, the adsorption column has some disadvantages such as the negligible by this system also supports this hypothesis. The second disadvantage of the charcoal is its low translarger reduction of red blood cells, platelets and albumin than those observed in the present device. port capacity. Our previous study showed that the estimated capacity to remove digoxin by charcoal is about Hybrid organs with tissue engineering have been reported mainly in primary cultures of hepatocytes for the 8.69 mg/3 h at a 50 mL/min of blood flow rate [4], which is only about 26% of capacity of the hybrid kidney obtreatment of liver failure [15, 16] . Recently, a hybrid organ with renal cells was reported for the treatment of acute tained in our current study. Although the blood flow rate was not same with this study and thus a precise comparirenal failure in dogs [17] . Although that report used primary culture of renal cells, it would be better to introson is impossible, we speculate that our novel system has a higher capacity, and may be superior to conventional duce specific gene(s) to the cells if the modified cells have the enhanced transport capacity of the substrates. hemoperfusion with respect to both efficacy and safety. Indeed, with this device digoxin clearance is almost equivIf we obtain gene-introduced cells that possess specific physiological/pharmacological functions, such cells may alent to its renal clearance and about half of total body clearance in normal dogs [9] . For the treatment of human apply to this new cell culture system and thus provide specific functions to patients. Thus, our system may be subjects, this system should be up-scaled more than fivefold because digoxin clearance in humans is about 100 mL/ useful not only for the treatment of digoxin intoxication, but also for compensation of physiological function. If min [10] . Further evaluation is needed before applying this system to human subjects. The priming volume of the elimination mechanisms of uremic toxin(s) from the kidney are fully understood, a hybrid kidney with an the whole system in our current study is about 110 mL; the volume for each mini-module is about 5 mL and the introduction of the genes to renal cells may be a more powerful tool for the treatment of renal failure. We volume of tubing to connect the whole system is about 60 mL. Because this system requires that it be scaled up seeded the cells on the outside of the hollow fiber, while Humes et al seeded on the inside [17] . We believe that to about fivefold for humans and it is complicated, it needs to be modified and simplified for clinical situations.
there are two advantages in our system. (1) We are afraid that because the inner diameter of the module is very Treatment of digoxin intoxication should be required for emergency situations. As described in our earlier small, cells cultured on the inner surfaces of the fibers may obstruct blood flow during the treatment. (2) There article, we need to wait about a week to use this column after the culture is started [3] . In addition, the maximum is a concern about the contact of non-human cells with human blood during the treatment. Because of species capacity of drug removal in this device can be obtained on days 7 to 10 after the cells are cultured [3] . Thus, we difference, unexpected immunological problems might
